Erratum: Disruption of NAD(P)H:quinone oxidoreductase 1 gene in mice leads to 20S proteasomal degradation of p63 resulting in thinning of epithelium and chemical-induced skin cancer (Oncogene (2011) 30 (1098-1107) DOI: 10.1038/onc.2010.491);Disruption of NAD(P)H: Quinone oxidoreductase 1 gene in mice leads to 20S proteasomal degradation of p63 resulting in thinning of epithelium and chemical-induced skin cancer

Oncogene

Volumn 30, Issue 9, 2011, Pages 1098-1107

  Patrick, B A ^a   Gong, X ^b   Jaiswal, A K ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

20S proteasome; carcinogenicity; NQO1; p63; skin differentiation

Indexed keywords

BENZO[A]PYRENE; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CYTOKERATIN 14; PROTEASOME; PROTEIN P63; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE QUINONE OXIDOREDUCTASE 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CELL DIFFERENTIATION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DISEASE MARKER; DOWN REGULATION; ENZYME ACTIVITY; GENE DISRUPTION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; IMMUNOPRECIPITATION; KERATINOCYTE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; SKIN CANCER; SKIN CARCINOGENESIS; SKIN EPITHELIUM; SKIN FIBROBLAST; SKIN PROTECTION; WESTERN BLOTTING;

MUS;

EID: 79952281710     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2016.475     Document Type: Erratum

References (34)

1. Ahn KS, Sethi G, Jain AK, Jaiswal AK, Aggarwal BB. (2006). Genetic deletion of NAD(P)H:quinone oxidoreductase 1 abrogates activation of nuclear factor-kappaB, IkappaBalpha kinase, c-Jun N-terminal kinase, Akt, p38, and p44/42 mitogen-activated protein kinases and potentiates apoptosis. J Biol Chem 281: 19798-19808. (Pubitemid 44065754)
2. Arrowsmith CH. (1999). Structure and function of the p53 family. Cell Death Differ 12: 1169-1173.
3. Asher G, Dym O, Tsvetkov P, Adler J, Shaul Y. (2006). The crystal structure of NAD(P)H quinone oxidoreductase 1 in complex with its potent inhibitor dicoumarol. Biochemistry 45: 6372-6378. (Pubitemid 43787804)
4. Asher G, Tsvetkov P, Kahana C, Shaul Y. (2005). A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73. Genes Dev 19: 316-321. (Pubitemid 40189294)
5. Candi E, Cipollone R, Rivetti di Val Cervo P, Gonfloni S, Melino G, Knight R. (2008). p63 in epithelial development. Cell Mol Life Sci 65: 3126-3133.
6. Chen S, Wu K, Knox R. (2000). Structure-function studies of DT-diaphorase (NQO1) and NRH:quinone oxidoreductase (NQO2). Free Rad Biol Med 29: 276-284.
7. Das A, Kole L, Wang L, Barrios R, Moorthy B, Jaiswal AK. (2006). BALT development and augmentation of hyperoxic lung injury in mice deficient in NQO1 and NQO2. Free Radic Biol Med 40: 1843-1856.
8. Fuchs E. (1996). The cytoskeleton and disease: genetic disorders of intermediate filaments. Annu Rev Genet 30: 197-231. (Pubitemid 27014468)
9. Gelboin HV. (1980). Benzo[a]pyrene metabolism, activation and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes. Physiol Rev 60: 1107-1166.
10. Gong X, Kole L, Iskander K, Jaiswal AK. (2007). NRH:quinone oxidoreductase 2 and NAD(P)H:quinone oxidoreductase 1protect tumor suppressor p53 against 20S proteasomal degradation leading to stabilization and activation of p53. Cancer Res 67: 5380-5388. (Pubitemid 46997278)
11. Guengerich FP. (1988). Roles of cytochromes P-450 enzymes in chemical carcinogenesis and cancer chemotherapy. Cancer Res 48: 2946-2954.
12. Iskander K, Paquet M, Brayton C, Jaiswal AK. (2004). Deficiency of NRH:quinine oxidoreductase 2 increases susceptibility to 7,12-dimethylbenz(a) anthracene and benzo(a)pyrene-induced skin carci-nogenesis. Cancer Res 64: 5925-5928. (Pubitemid 39129385)
13. Jaiswal AK. (2004). Nrf2 Signaling in coordinated activation of antioxidant gene expression. Free Rad Biol Med 36: 1199-1207. (Pubitemid 38526313)
14. Joseph P, Jaiswal AK. (1994). NAD(P)H:quinone oxidoreductase 1 (DT diaphorase) specifically prevents the formation of benzo[a]pyr-ene quinone-DNA adducts generated by cytochrome P4501A1 and P450 reductase. Proc Natl Acad Sci USA 91: 8413-8417. (Pubitemid 24273674)
15. Joseph P, Jaiswal AK. (1998). NAD(P)H:quinone oxidoreductase1 (NQO1) reduces the mutagenicity of DNA caused by NAD(P)H:P450 reductase activated metabolites of benzo[a]pyrene quinones. Br J Cancer 77: 709-719. (Pubitemid 28077457)
16. 0 and lead to cellular transformation and in vivo tumorigenesis. Br J Cancer 78: 312-320.
17. King KE, Weinberg WC. (2007). P63: defining roles in morphogenesis, homeostasis, and neoplasia of the epidermis. Mol Carcinog 46: 716-724. (Pubitemid 47255193)
18. Koster MI, Dai D, Marinari B, Sano Y, Costanzo A, Karin M et al. (2007a). p63 induces key target genes required for epidermal morphogenesis. Proc Natl Acad Sci USA 104: 3255-3260. (Pubitemid 46364146)
19. Koster MI, Dai D, Roop DR. (2007b). Conflicting roles for p63 in skin development and carcinogenesis. Cell Cycle 6: 269-273.
20. Long II DJ, Iskander K, Gaikwad A, Arin M, Roop DR, Knox R et al. (2002). Disruption of dihydronicotinamide riboside:quinone oxidoreductase 2 (NQO2) leads to myeloid hyperplasia of bone marrow and decreased sensitivity to menadione toxicity. J Biol Chem 277: 46131-46139. (Pubitemid 35417602)
21. Long II DJ, Waikel RL, Wang XJ, Perlaky L, Roop DR, Jaiswal AK. (2000). NAD(P)H:quinine oxidoreductase 1 deficiency increases susceptibility to benzo(a)pyrene induced mouse skin carcinogenesis. Cancer Res 60: 5913-5915.
22. Long II DJ, Waikel RL, Wang XJ, Roop DR, Jaiswal AK. (2001). NAD(P)H:quinine oxidoreductase1 deficiency and increased susceptibility to 7,12-dimethylbenz[a]-anthracene-induced carcinogen-esis in mouse skin. J Natl Cancer Inst 93: 1166-1170. (Pubitemid 32780969)
23. Melino G, Gallagher E, Aqeilan RI, Knight R, Peschiaroli A, Rossi M et al. (2008). Itch: a HECT-type E3 ligase regulating immunity, skin, and cancer. Cell Death Differ 15: 1103-1112. (Pubitemid 351850962)
24. Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, Bradley A. (1999). p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398: 708-713. (Pubitemid 29197649)
25. Moll UM, Slade N. (2004). p63 and p73: Roles in development and tumor formation. Mol Cancer Res 2: 371-386. (Pubitemid 39031071)
26. Pietsch EC, Sykes SM, McMahon SB, Murphy SE. (2008). The p53 family and programmed cell death. Oncogene 27: 6507-6521.
27. Radjendirane V, Joseph P, Jaiswal AK. (1997). Gene expression of DT-diaphorase (NQO1) in cancer cells. In: Forman HJ, Cadenas E (eds). Oxidative Stress and Signal Transduction. Chapman & Hall: New York. pp 441-475.
28. Radjendirane V, Joseph P, Lee YH, Kimura S, Klein-Szanto AJ, Gonzalez FJ et al. (1998). Disruption of the DT diaphorase (NQO1) gene in mice leads to increased menadione toxicity. J Biol Chem 273: 7382-7389. (Pubitemid 28152759)
29. Romano RA, Ortt K, Birkaya B, Smalley K, Sinha S. (2009). An active role of the DeltaN isoform of p63 in regulating basal keratin genes K5 and K14 and directing epidermal cell fate. PLoS One 4: e5623.
30. Ross D, Kepa JK, Winski SL, Beall HD, Anwar A, Siegel D. (2000). NAD(P)H:quinone oxidoreductase1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphism. Chem Biol Interact 129: 77-97.
31. Salvat C, Acquaviva C, Scheffner M, Robbins I, Piechaczyk M, Jariel-Encontre I et al. (2000). Molecular characterization of the thermosensitive E1 ubiquitin-activating enzyme cell mutant A31N-ts20. Eur J Biochem 267: 3712-3722.
32. Shen J, Barrios RJ, Jaiswal AK. (2010). Inactivation of the quinine oxidoreductases NQO1 and NQO2 strongly elevates the incidence and multiplicity of chemically induced skin tumors. Cancer Res 70: 1006-1014.
33. Talalay P, Fahey JW, Holtzclaw WD, Prestera T, Zhang Y. (1995). Chemoprotection against cancer by phase 2 enzyme induction. Toxicol Lett 82-83, 173-179 (Pubitemid 26057505)
34. Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Bronson RT et al. (1999). p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398: 714-718. (Pubitemid 29197650)